Tirzepatide half-life is about 5 days, which is why it is dosed weekly. Learn how long the drug stays in your system and what affects clearance.
Tirzepatide has an elimination half-life of about 5 days in humans. In practical terms, that means roughly 20 to 30 days — about four to five half-lives — pass before most of the drug has left your body after your final injection. This long half-life is the main reason tirzepatide, sold in the US as Mounjaro and Zepbound, is given as a once-weekly subcutaneous injection.
What "Half-Life" Actually Means
A drug's half-life is the time it takes your body to clear half of whatever amount is currently circulating. It is not the same as how long a drug works. After one half-life, half remains; after two, a quarter remains; after three, an eighth.
Understanding the half life of tirzepatide matters for two practical reasons. First, it explains why the medication builds up in your bloodstream over the first several weekly doses. Second, it explains why appetite changes or side effects can linger for days or weeks after you lower a dose or stop treatment.
How Long Does Tirzepatide Stay in Your System?
Most people clear the majority of tirzepatide within about a month of their last dose. The typical timeline looks like this:
- Day 0: final injection.
- Around day 5: roughly half the dose remains.
- Around day 10: roughly a quarter remains.
- Around day 15: roughly one-eighth remains.
- Days 20 to 30: most of the drug is gone, with only trace amounts possibly detectable.
These figures are averages, not guarantees. Individual clearance can vary with body composition, kidney function, and other factors, so some people notice effects fading faster or slower than the timeline above. Importantly, half-life does not change with dose — a 2.5 mg injection and a 15 mg injection clear at the same rate, even though the higher dose leaves more drug in your system overall.
Why Tirzepatide Is Dosed Once a Week
Tirzepatide reaches steady state after about four weekly doses. Because each injection overlaps with the previous one, blood levels rise gradually and then level off. That plateau is what makes a stable weekly schedule work.
Peak plasma concentrations typically appear about 8 to 72 hours after an injection, then decline slowly. The tirzepatide half life of roughly 5 days sits in a useful range for weekly dosing: short enough that the drug does not accumulate indefinitely, long enough that levels stay relatively steady between shots.
What Affects Tirzepatide Clearance
Tirzepatide is not broken down by the liver's CYP450 enzyme system. Instead, it is degraded through general protein metabolism after its fatty-acid portion is cleaved. That has a few practical consequences:
- Kidney or liver impairment: No dose adjustment is required based on the prescribing information.
- Body weight: Weight influences distribution somewhat, but dosing is titration-based rather than weight-based.
- Injection site: Abdomen, thigh, and upper arm injections produce similar overall exposure.
- Age and sex: No clinically meaningful differences have been reported.
What does change your experience is the dose itself, along with how long you have been taking the medication. Higher doses and longer treatment both mean more drug is present when you stop.
How Tirzepatide Compares With Other Peptides
Half-life varies enormously across peptides and injectable medications. The table below shows how tirzepatide compares with a few well-known compounds.
| Compound | Approximate half-life | Typical dosing |
|---|---|---|
| Tirzepatide | ~5 days | Once weekly |
| Semaglutide | ~7 days | Once weekly |
| Dulaglutide | ~5 days | Once weekly |
| Liraglutide | ~13 hours | Once daily |
| Somatropin (HGH) | ~3 to 4 hours | Often daily |
| PT-141 (bremelanotide) | ~2.7 hours | As needed |
| Melanotan II | ~1 hour (reported) | Not FDA-approved |
Other peptides used in research move through the body much faster than tirzepatide. For example, the somatropin half-life is measured in hours, which is why growth hormone is typically injected daily rather than weekly.
Compounds studied for other purposes clear even faster. The pt-141 half-life is roughly 2.7 hours, and the melanotan ii half life is reported at around an hour in limited studies. The mots-c half-life has not been well established in humans, and published estimates vary widely. Melanotan II and MOTS-c are not FDA-approved for human use, and anyone considering an unapproved peptide should speak with a healthcare professional first.
Missed Doses, Stopping Treatment, and Side Effects
Because tirzepatide clears slowly, a single missed dose is unlikely to cause an immediate loss of effect. The label guidance is straightforward:
- If you remember within 4 days (96 hours) of your scheduled dose, take it as soon as possible.
- If more than 4 days have passed, skip the missed dose and resume your normal weekly schedule.
- Never double up to make up for a missed injection.
Stopping treatment is a separate decision. Appetite suppression and blood sugar effects taper over several weeks rather than disappearing overnight, and weight regain after discontinuation is common. Talk with a healthcare professional before stopping, restarting, or changing your dose.
Gastrointestinal side effects such as nausea, vomiting, and diarrhea are the most commonly reported issues. Because the drug lingers, those effects can take days to weeks to ease after a dose reduction. Seek medical care for severe or persistent abdominal pain, signs of dehydration, or vision changes.
Frequently Asked Questions
How long does tirzepatide stay in your system after your last dose?
With a half-life of about 5 days, most of the drug is cleared within roughly 20 to 30 days after your final injection. Trace amounts may be detectable slightly longer, and individual clearance varies. Effects such as appetite suppression typically fade gradually over that same window.
Is tirzepatide's half-life longer than semaglutide's?
No. Semaglutide's half-life is about 7 days, which is slightly longer than tirzepatide's roughly 5 days. Both medications are dosed once weekly, so this difference rarely changes how they are used in practice.
Does tirzepatide build up in your body with weekly dosing?
Yes. Once-weekly dosing causes tirzepatide to accumulate until steady state, which is reached after about four doses. That accumulation is intentional and helps keep drug levels consistent between injections.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.